Rajeev Singh
Central Business Development Manager @WACKER
Signup · Get unlimited contacts
WORK HISTORY
Central Business Development Manager @WACKER
Ravensburg, DE
Leading global business development initiatives within Wacker’s biologics CDMO portfolio, with a strong focus on mRNA-based therapeutics and pandemic preparedness programs.Key Responsibilities & Achievements: Acquired new CDMO projects, specializing in mRNA-based drug products, expanding Wacker’s footprint in next-generation biopharmaceuticals Drafted and negotiated NDAs, proposals, and contracts for the GMP-compliant development and manufacturing of biologic drug substances Represented Wacker at international industry events and exhibitions, positioning the company as a leading partner for biologics manufacturing Maintained and updated the global customer database, supporting lead generation, qualification, and long-term account engagement Acted as the strategic interface with internal Program Management, ensuring smooth project transitions and cross-functional alignment Created and managed communication assets — brochures, technical datasheets, posters, digital and print advertisements — to support BD and marketing initiatives Expanded Wacker’s global CDMO outreach, engaging with international biotech clients and negotiating with government agencies under the pandemic preparedness umbrella — including collaboration with ZEPAI and the European Vaccine Hub
EDUCATION
Marburg University
Research Doctorate, Oncology and Cancer Biology
The Martin Luther University of Halle-Wittenberg
Master's degree, Pharmaceutical Biotechnology
SRM University (Sri Ramaswamy Memorial University)
Bachelor's degree, Biotechnology
Lucknow Public School, Lucknow India
High School, Biology/Biological Sciences, General
ABOUT RAJEEV SINGH
Scientist by foundation, strategist by evolution — I bring over a decade of experience across oncology research, biologics development, and commercial strategy within the global biotech and CDMO landscape.Beginning in oncology R&D, I developed a rigorous scientific mindset and a deep appreciation for innovation in drug discovery. Over the past several years, I’ve transitioned into business-facing roles where I’ve led strategic initiatives, cultivated client partnerships, and delivered growth across complex biologics platforms — including mRNA, aseptic fill-finish, and drug substance development.My professional journey spans North America, Europe, and Asia, giving me a global perspective on regulatory pathways, partner engagement, and the operational nuances of biologics manufacturing. I’ve worked across diverse therapeutic modalities and project scales — from early development to late-phase commercialization — with a strong focus on building value through collaboration, precision, and execution. Areas of Expertise:Biologics & mRNA-based therapeuticsOncology and translational researchCDMO strategy: Drug Substance & Drug Product (Fill-Finish)Business development, partnership management, and growth strategyGlobal project execution and cross-cultural collaborationI thrive at the intersection of science and strategy — where technical depth meets business insight — and am driven by the challenge of transforming complex therapeutic programs into real-world solutions.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.